HLA-G CAR-T / Korea Kolmar - LARVOL DELTA

A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors (clinicaltrials.gov) - P1/2 | N=31 | Active, not recruiting | Sponsor: M.D. Anderson Cancer Center | Trial completion date: Dec 2029 ➔ Dec 2028 | Trial primary completion date: Jun 2026 ➔ Jun 2028

Trial completion date • Trial primary completion date • Oncology • Ovarian Cancer • Renal Cell Carcinoma • Solid Tumor • BRCA • BRCA1 • BRCA2 • HLA-G

A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors (clinicaltrials.gov) - P1/2 | N=31 | Active, not recruiting | Sponsor: M.D. Anderson Cancer Center | Recruiting ➔ Active, not recruiting | N=117 ➔ 31

Enrollment change • Enrollment closed • Ovarian Cancer • Renal Cell Carcinoma • Solid Tumor • BRCA • BRCA1 • BRCA2 • HLA-G